News from Zyme and the companies we work with.
TRIMTECH Therapeutics appoints Alison Lawton as Chair of the Board
Experienced biotech Chair and executive will guide corporate growth and development Cambridge, UK, 2 December 2025: TRIMTECH Therapeutics, a biotechnology company developing novel small molecule therapies that target and degrade [...]
Atelerix and Labskin partner to enable long-distance transport of advanced in vitro skin models
Agreement to broaden access, streamline logistics, and reduce variability associated with temperature-sensitive shipping of 3D tissue models, without cryopreservation Joint webinar to present trial performance data and best-practice workflows for [...]
OBN Awards 2025 celebrate the most exciting innovations and inspiring achievements happening across the Life Sciences industry
Abingdon, UK, 27 November 2025: – OBN (UK) Ltd, the membership organisation whose mission is to catalyse success in the life science industry, is thrilled to announce the winners of [...]
SPT Labtech enables automated PacBio Kinnex full-length RNA-seq library preparation workflow on SPT’s firefly platform
Automation of Kinnex full-length RNA-seq kit on firefly platform streamlines library preparation for large-scale transcriptomic studies Validated at Seattle Children’s Genomics & Spatial Biology CoLab, the workflow delivers consistent, high-quality [...]
Scottish Brain Sciences opens new Alzheimer’s clinical research centre at ONE BioHub
Aberdeen clinical research centre widens access to clinical trials across Scotland, advancing early Alzheimer’s research ONE BioHub provides Scottish Brain Sciences with infrastructure and integrated support to scale operations and [...]
Mosaic Therapeutics appoints Dr Stephen Shuttleworth as Chief Scientific Officer
Venture Partner at Samsara BioCapital, and former CSO and COO of Karus Therapeutics, brings deep scientific and industry experience to Mosaic’s Executive Leadership team Stephen will lead the Company’s scientific [...]
Mursla Bio collaborates with a leading global pharma company to advance biomarker-guided precision medicine in MASH
Mursla Bio’s AI Precision Medicine Platform to inform drug development and patient stratification in metabolic liver disease Cambridge, UK, and Boston MA, USA, 13 November 2025: Mursla Bio, a leader [...]
Shift Bioscience publishes improved metric calibration framework for robust genetic perturbation modeling using AI Virtual Cells
AI virtual cells outperform key baselines on well-calibrated metrics, challenging prior reports of poor model performance Foundational research reinforces the use of virtual cell models to accelerate target identification pipelines [...]
TRIMTECH Therapeutics appoints Dr Mike Hutton to Scientific Advisory Board
Industry leader brings deep expertise across neurodegenerative disease therapeutics development Dr Hutton joins Prof. Alessio Ciulli FRS and Dr Adam Gilbert on SAB Cambridge, UK, 11 November 2025: TRIMTECH Therapeutics, [...]
SPT Labtech and Alithea Genomics Collaborate to Automate Ultra Sensitive Single-Cell Transcriptomic Workflows
Integrates Alithea Genomics’ MERCURIUS FLASH-seq single-cell RNA-seq protocol with SPT Labtech’s firefly liquid handling platform Enables higher-throughput, cost efficient single-cell sequencing Cambridge, UK, and Lausanne, Switzerland, 05 November 2025: SPT [...]
Optibrium Delivers Real-Time Collaboration in its Comprehensive Molecular Design Platform with StarDrop 8
Latest release accelerates hit-to-candidate progression by keeping teams aligned, eliminating inefficiencies and enabling better prioritisation decisions CAMBRIDGE, UK, 04 November 2025 – Optibrium, a leading developer of software and AI [...]
Nuclera expands access to eProtein Discovery for APAC customers with distributor agreement in Australia and New Zealand
Partnership with Solve Scientific strengthens international sales as part of ongoing global expansion Cambridge, UK, and Boston MA, USA, 03 November 2025: Nuclera, the biotechnology company accelerating drug discovery by [...]
